Prion disease surveillance in Japan: Analysis of 1,241 patients

Clinical Neurology

Volumn 49, Issue 11, 2009, Pages 939-942

  Yamada, Masahito ^a,f   Nozaki, Ichiro ^a   Hamaguchi, Tsuyoshi ^a   Noguchi Shinohara, Moeko ^a   Kitamoto, Tetsuyuki ^b,f   Nakamura, Yosikazu ^c,f   Sato, Takeshi ^d,f   Mizusawa, Hidehiro ^e,f  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Higashi Yamato Hospital   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f CJD Surveillance Committee ^*  (Japan)

Author keywords

Creutzfeldt Jakob disease (CJD); Dura mater graft associated CJD; Japan; Prion diseases; Variant CJD

Indexed keywords

PRION PROTEIN;

ANAMNESIS; BLOOD TRANSFUSION; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DISEASE SURVEILLANCE; DURA MATER; ELECTROENCEPHALOGRAM; EYE SURGERY; GENE MUTATION; HUMAN; IATROGENIC DISEASE; JAPAN; MAJOR CLINICAL STUDY; NEUROSURGERY; PRION DISEASE; RISK REDUCTION; SPORADIC CREUTZFELDT JAKOB DISEASE; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE; ARTICLE; CLASSIFICATION; DISEASE TRANSMISSION; GENETICS; MUTATION; PRION; TIME; TRANSPLANTATION;

CREUTZFELDT-JAKOB SYNDROME; DURA MATER; HUMANS; JAPAN; MUTATION; PRION DISEASES; PRIONS; TIME FACTORS;

EID: 77956196355     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.49.939     Document Type: Conference Paper

References (10)

1. Hamaguchi T, Kitamoto T, Sato T, et al: Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 2005; 64: 643-648 (Pubitemid 40261892)
2. Koväcs GG, Puopolo M, Ladogana A, et al: Genetic prion disease: the EUPOCD experience. Hum Genet 2005; 118: 166-174 (Pubitemid 41672078)
3. Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, et al: Clinical features and diagnosis of dura mater graft-associated Creutzfledt-Jakob disease. Neurology 2007; 69: 360-367 (Pubitemid 47205663)
4. Kobayashi A, Asano M, Mohri S, et al: Cross-sequence transmission of sporadic Creutzfleldt-Jakob disease (CJD) creates a new prion strain. J Biol Chem 2007; 282: 30022-30028
5. World Health Organization: The revision of the surveillance case definition for variant Creutzfeldt-Jakob Disease (vCJD). Report of a WHO consultation Edinburgh, United Kingdom 17 May 2001 (available at http://www.who.int/csr/resources/publications/bse/en/whocdscsreph20015.pdf)
6. Yamada M on behalf of vCJD Working Group: The first Japanese case of variant CJD showing periodic electroencephalogram. Lancet 2006; 367: 874
7. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, et al: Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Infect Dis 2009; 15: 265-271
8. Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, et al: Ophthalmic surgery in prion diseases. Emerg Infect Dis 2007; 13: 162-164 (Pubitemid 46057859)
9. (available at: http://www.mhlw.go.jp/shingi/2008/07/dl/s0709-9d.pdf)
10. (available at: http://www.nanbyou.or.jp/pdf/cjd-2008.pdf)